MedTech-related health technology assessments from NIHR in September 2021

21

Oct 2021

The National Institute for Health Research (NIHR) funds valuable independent research for health and social care decision-makers in England. Reports from the Health Technology Assessment (HTA) Programme are published in the NIHR HTA Journal and inform NICE guidance.

In September 2021, two MedTech-related assessments were published in the NIHR HTA Journal:

  • Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluation. Two products were assessed: QAngio XA 3D/QFR (three-dimensional/quantitative flow ratio) and CAAS vFFR (vessel fractional flow reserve). It was concluded that the quantitative flow ratio measured by QAngio XA 3D/QFR has a good agreement and diagnostic accuracy compared with invasive FFR and is preferable to standard invasive coronary angiography alone. QAngio XA 3D/QFR has similar cost-effectiveness to invasive FFR and, therefore, could be a reasonable alternative. The clinical effectiveness and cost-effectiveness of CAAS vFFR are uncertain.
  • A prognostic model, including quantitative fetal fibronectin, to predict preterm labor: the QUIDS meta-analysis and prospective cohort study Measurement of fetal fibronectin in vaginal fluid is a biochemical test that can indicate impending preterm birth. It was concluded that a prognostic model including quantitative fetal fibronectin and clinical risk factors showed excellent performance in the prediction of spontaneous preterm birth within seven days of the test. The model is cost-effective and can be used to help guide management decisions for women with threatened preterm labor. The model will be embedded in electronic maternity records and a mobile application, enabling further data collection for refinement and validation.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

26

Jan 2023

The updated German Uniform Evaluation Standard (EBM) catalog came into force on January 1, 2023. The EBM catalog (Einheitlicher Bewertungsmaßstab) regulates the reimbursement of services in the public outpatient sector in Germany and is updated once a quarter (four times a year). Among other changes, a new code for "zanadio" health app for follow-up and evaluation was introduced in the catalog.

Read more

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

23

Jan 2023

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

Read more

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more